SEC Filings
Venrock Funds Take 5.1% Stake In Entera Bio, 8.9 Million Shares
The seven-member Venrock group reports a passive position in the oral-drug developer, and certifies it is not seeking control.
ENTX
Entera Bio (ENTX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Entera Bio Adds Organon's Research Chief To Its Board As Director Haya Taitel Steps Down
Dr. Juan Camilo Arjona Ferreira takes a Class II seat and a compensation committee post on December 1.
SEC Filings
Entera Bio Asks Shareholders To Approve Pay Rewrite After Review Found Compensation Below Market
Five of eight proposals on the November 24 ballot trace to the July private placement of about $275 million, the proxy says.
SEC Filings
Entera Bio Adds Ex-Gilead Commercial Head Laura Hamill To Board As 16-Year Director Malca Steps Down
An 8-K says Hamill, who led about 2,500 Gilead staff, takes a Class I seat on December 1, 2026, replacing Yonatan Malca.